The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO)
NCT ID: NCT06957613
Last Updated: 2025-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2017-07-01
2032-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s
NCT04011527
Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion
NCT02026466
Computed Tomography Angiography Prediction Score for Percutaneous Revascularization of Chronic Total Occlusions
NCT02022878
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
NCT02061436
Chronic Total Occlusion Registry
NCT02352818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Coronary Chronic Total Occlusions
Patients undergoing Recanalization for Coronary Chronic Total Occlusions
Revascularization/Conservative management
Percutaneous Transluminal Angioplasty of Coronary Chronic Total Occlusions via Dedicated Drug Eluting Stents and/or Balloons.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Revascularization/Conservative management
Percutaneous Transluminal Angioplasty of Coronary Chronic Total Occlusions via Dedicated Drug Eluting Stents and/or Balloons.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Segeberger Kliniken GmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Holger Nef, Prof., MD
Role: STUDY_DIRECTOR
Herzzentrum Segeberger Kliniken GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herzzentrum Segeberger Kliniken GmbH
Bad Segeberg, Schleswig-Holstein, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SK 112 - 168/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.